South Dakota AG Marty Jackley is introducing a series of bills for the 2026 legislative session aimed at strengthening laws ...

South Dakota Attorney General Marty Jackley has introduced three main issues he plans to bring legislation on in January 2026 ...

The results revealed a clear sequence. Enzymes predating cannabis showed no ability to process CBGA. The first enzyme unique ...

Cannabis with high levels of tetrahydrocannabinol is associated with short-term improvement in pain vs placebo, but also ...

Ohio lawmakers just voted to restrict most hemp products, but THC-infused beverages will be available at least through the end of 2026. Here's what you need to know. Senate Bill 56, which heads to Gov ...

President Donald Trump is considering an executive order aimed at easing federal marijuana restrictions, according to reports by The Washington Post and CNBC, in a move that would make it easier to ...

President Trump said Monday his administration is “considering” reclassifying marijuana as a less dangerous drug, days after The Washington Post reported he is expected to sign an executive order ...

Dr. Carroll is a pediatrician and health policy expert. President Trump ordered marijuana to be rescheduled under federal law on Thursday, shifting it out of the most restrictive drug category. The ...

Today is a good day for potheads, and a great one for the nation’s state-regulated marijuana businesses. In a historic move, the federal government will reclassify cannabis to a more lenient category.

Weed Backer: if President Trump reclassifies cannabis as a Schedule III drug—on par with mild painkillers—it will be the biggest drug policy reform since 1970. According to The Post’s report on ...

WASHINGTON, Dec 15 (Reuters) - U.S. President Donald Trump said on Monday he is considering an executive order to reclassify marijuana as a less dangerous drug — a decision that could reshape the ...

WASHINGTON — President Donald Trump signed an executive order Thursday that could reclassify marijuana as a less dangerous drug and open new avenues for medical research, a major shift in federal drug ...